MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202517016029 A) filed by Treefrog Therapeutics, Pessac, France, on Feb. 24, for 'extracellular matrix substitute in a cellular microcompartment.'
Inventor(s) include Rieu, Clement; Mianne, Joffrey; Warter, Elise; and Feyeux, Maxime.
The application for the patent was published on May 9, under issue no. 19/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to a cellular microcompartment that can be used clinically, termed "GMP", comprising at least: a. a cell layer, b. an external hydrogel layer, and c. a fibrin mesh placed between the external hydrogel layer and said cell layer. The invention also relat...